GROUP ONE TRADING, L.P. - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$314,565
+53.0%
45,989
+103.1%
0.00%0.0%
Q2 2023$205,553
+252.1%
22,638
+150.5%
0.00%
Q1 2023$58,373
+601.8%
9,036
+588.7%
0.00%
Q4 2022$8,318
-96.3%
1,312
-96.4%
0.00%
Q3 2022$224,000
-24.3%
36,156
+8.0%
0.00%
Q2 2022$296,000
+46.5%
33,473
+39.7%
0.00%
Q1 2022$202,000
-35.7%
23,954
-22.3%
0.00%
Q4 2021$314,000
-9.2%
30,827
+73.1%
0.00%
Q3 2021$346,000
+322.0%
17,806
+280.8%
0.00%
Q2 2021$82,0004,6760.00%
Other shareholders
INMUNE BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders